| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 23 | 2021 | 1669 | 1.610 |
Why?
|
| Thrombin | 6 | 2003 | 22 | 0.810 |
Why?
|
| Ultrasonography, Doppler | 3 | 2010 | 27 | 0.640 |
Why?
|
| Aneurysm, False | 6 | 2003 | 50 | 0.630 |
Why?
|
| Postoperative Complications | 6 | 2017 | 1294 | 0.620 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2013 | 9 | 0.600 |
Why?
|
| Hemostatics | 4 | 2003 | 27 | 0.580 |
Why?
|
| Portal Vein | 4 | 2010 | 38 | 0.570 |
Why?
|
| Adenocarcinoma | 5 | 2008 | 355 | 0.520 |
Why?
|
| Coronary Artery Disease | 2 | 2014 | 320 | 0.520 |
Why?
|
| Contrast Media | 9 | 2015 | 429 | 0.500 |
Why?
|
| Middle Aged | 42 | 2018 | 17898 | 0.490 |
Why?
|
| Catheter Ablation | 4 | 2012 | 155 | 0.490 |
Why?
|
| Catheterization | 5 | 2007 | 113 | 0.480 |
Why?
|
| Thrombophlebitis | 4 | 1999 | 14 | 0.410 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 75 | 0.410 |
Why?
|
| Software | 3 | 2014 | 388 | 0.400 |
Why?
|
| Calcinosis | 1 | 2014 | 86 | 0.400 |
Why?
|
| Hypertension, Portal | 1 | 2013 | 19 | 0.400 |
Why?
|
| Coronary Angiography | 1 | 2014 | 209 | 0.390 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 58 | 0.390 |
Why?
|
| Femoral Artery | 3 | 2003 | 99 | 0.390 |
Why?
|
| Male | 44 | 2018 | 30294 | 0.390 |
Why?
|
| Aged, 80 and over | 19 | 2018 | 5520 | 0.380 |
Why?
|
| Pancreas | 2 | 2014 | 154 | 0.370 |
Why?
|
| Mesenteric Lymphadenitis | 1 | 2012 | 2 | 0.370 |
Why?
|
| Liver Transplantation | 2 | 2012 | 217 | 0.360 |
Why?
|
| Liver Neoplasms | 2 | 2012 | 306 | 0.360 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 53 | 0.350 |
Why?
|
| Aged | 26 | 2018 | 14648 | 0.350 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 266 | 0.350 |
Why?
|
| Intestine, Small | 2 | 2005 | 80 | 0.350 |
Why?
|
| Female | 41 | 2018 | 33350 | 0.350 |
Why?
|
| Algorithms | 3 | 2014 | 1028 | 0.340 |
Why?
|
| Catheters, Indwelling | 3 | 2007 | 68 | 0.330 |
Why?
|
| Humans | 58 | 2021 | 64238 | 0.330 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2000 | 12 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 181 | 0.310 |
Why?
|
| Femoral Vein | 2 | 2007 | 18 | 0.310 |
Why?
|
| Adult | 25 | 2018 | 17116 | 0.310 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 358 | 0.310 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2006 | 60 | 0.300 |
Why?
|
| Pancreatic Neoplasms | 4 | 2004 | 349 | 0.300 |
Why?
|
| Iopamidol | 3 | 2012 | 13 | 0.290 |
Why?
|
| Catheterization, Central Venous | 3 | 2006 | 83 | 0.280 |
Why?
|
| Sigmoid Neoplasms | 1 | 2008 | 2 | 0.280 |
Why?
|
| Sigmoid Diseases | 1 | 2008 | 6 | 0.280 |
Why?
|
| Sensitivity and Specificity | 8 | 2014 | 1162 | 0.280 |
Why?
|
| Diverticulitis, Colonic | 1 | 2008 | 37 | 0.270 |
Why?
|
| Aorta, Abdominal | 2 | 1998 | 56 | 0.270 |
Why?
|
| Terminology as Topic | 2 | 2000 | 141 | 0.260 |
Why?
|
| Common Bile Duct | 2 | 2004 | 19 | 0.260 |
Why?
|
| Carotid Arteries | 1 | 2007 | 61 | 0.260 |
Why?
|
| Carotid Artery Diseases | 1 | 2007 | 61 | 0.250 |
Why?
|
| Iatrogenic Disease | 3 | 2003 | 58 | 0.250 |
Why?
|
| Fibrin | 1 | 2006 | 19 | 0.250 |
Why?
|
| Incidental Findings | 3 | 2018 | 46 | 0.240 |
Why?
|
| Penile Erection | 1 | 2005 | 7 | 0.240 |
Why?
|
| Impotence, Vasculogenic | 1 | 2005 | 3 | 0.240 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2005 | 27 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 677 | 0.240 |
Why?
|
| Image-Guided Biopsy | 2 | 2017 | 50 | 0.230 |
Why?
|
| Stents | 3 | 2010 | 493 | 0.230 |
Why?
|
| Penis | 1 | 2005 | 38 | 0.230 |
Why?
|
| Piperazines | 1 | 2005 | 87 | 0.230 |
Why?
|
| Cystic Duct | 1 | 2004 | 5 | 0.220 |
Why?
|
| Renal Dialysis | 1 | 2006 | 195 | 0.220 |
Why?
|
| Biopsy | 2 | 2014 | 447 | 0.220 |
Why?
|
| Cholecystitis | 1 | 2004 | 29 | 0.220 |
Why?
|
| Retrospective Studies | 11 | 2021 | 6726 | 0.220 |
Why?
|
| Thrombosis | 2 | 2000 | 198 | 0.220 |
Why?
|
| Cholestasis | 1 | 2004 | 66 | 0.210 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 22 | 0.200 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2006 | 127 | 0.200 |
Why?
|
| Ultrasonography | 6 | 2010 | 486 | 0.200 |
Why?
|
| Radiography, Abdominal | 2 | 2017 | 26 | 0.200 |
Why?
|
| Colonic Diseases | 1 | 2003 | 35 | 0.200 |
Why?
|
| Hemorheology | 2 | 2000 | 6 | 0.200 |
Why?
|
| Radiography, Interventional | 3 | 2017 | 81 | 0.200 |
Why?
|
| Pulse | 2 | 2002 | 16 | 0.200 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 81 | 0.190 |
Why?
|
| Ultrasonic Therapy | 1 | 2002 | 9 | 0.190 |
Why?
|
| Bronchial Arteries | 1 | 2002 | 3 | 0.190 |
Why?
|
| Hemoptysis | 1 | 2002 | 8 | 0.190 |
Why?
|
| Ultrasonography, Interventional | 1 | 2003 | 116 | 0.180 |
Why?
|
| Gastric Fistula | 1 | 2002 | 4 | 0.180 |
Why?
|
| Cutaneous Fistula | 1 | 2002 | 7 | 0.180 |
Why?
|
| Feasibility Studies | 4 | 2008 | 575 | 0.180 |
Why?
|
| Cardiac Catheterization | 2 | 2001 | 292 | 0.180 |
Why?
|
| Device Removal | 1 | 2002 | 65 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 113 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2008 | 3315 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 695 | 0.170 |
Why?
|
| Fistula | 1 | 2001 | 15 | 0.170 |
Why?
|
| Pancreatic Fistula | 1 | 2001 | 19 | 0.170 |
Why?
|
| Splanchnic Circulation | 2 | 2000 | 16 | 0.170 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2001 | 65 | 0.170 |
Why?
|
| Liver Circulation | 1 | 2000 | 11 | 0.160 |
Why?
|
| Radiosurgery | 1 | 2021 | 69 | 0.160 |
Why?
|
| Brachial Artery | 2 | 1999 | 28 | 0.160 |
Why?
|
| Radiography | 3 | 2012 | 552 | 0.160 |
Why?
|
| Plasminogen Activators | 1 | 2000 | 10 | 0.160 |
Why?
|
| Skin Diseases | 1 | 2001 | 83 | 0.160 |
Why?
|
| Injections, Intravenous | 4 | 2005 | 156 | 0.160 |
Why?
|
| Pulmonary Embolism | 2 | 1999 | 176 | 0.150 |
Why?
|
| Fiducial Markers | 2 | 2021 | 4 | 0.150 |
Why?
|
| Embolization, Therapeutic | 1 | 2002 | 326 | 0.150 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 47 | 0.140 |
Why?
|
| Thoracic Neoplasms | 1 | 1998 | 14 | 0.140 |
Why?
|
| Abdominal Neoplasms | 1 | 1998 | 22 | 0.140 |
Why?
|
| Splenic Neoplasms | 1 | 2018 | 8 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2000 | 242 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2015 | 47 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 4 | 2001 | 25 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 984 | 0.120 |
Why?
|
| Renal Artery | 1 | 1996 | 36 | 0.120 |
Why?
|
| Diverticulum, Colon | 1 | 1995 | 5 | 0.120 |
Why?
|
| Drainage | 1 | 2017 | 155 | 0.120 |
Why?
|
| Phlebography | 3 | 2010 | 44 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2017 | 153 | 0.110 |
Why?
|
| Liposarcoma | 1 | 2015 | 8 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2017 | 317 | 0.110 |
Why?
|
| Vascular Neoplasms | 1 | 2015 | 18 | 0.110 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 32 | 0.110 |
Why?
|
| Models, Theoretical | 2 | 2008 | 272 | 0.110 |
Why?
|
| Regional Blood Flow | 2 | 2008 | 110 | 0.110 |
Why?
|
| Aortography | 3 | 2008 | 57 | 0.110 |
Why?
|
| Software Validation | 1 | 2014 | 9 | 0.110 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 214 | 0.110 |
Why?
|
| Forearm | 1 | 1994 | 22 | 0.100 |
Why?
|
| Vascular Diseases | 2 | 1995 | 82 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 98 | 0.100 |
Why?
|
| Pneumothorax | 1 | 2014 | 50 | 0.100 |
Why?
|
| Hand | 1 | 1994 | 73 | 0.100 |
Why?
|
| Swine | 3 | 2003 | 394 | 0.100 |
Why?
|
| Partial Thromboplastin Time | 1 | 1993 | 9 | 0.100 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1993 | 11 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 116 | 0.100 |
Why?
|
| Treatment Outcome | 6 | 2017 | 5691 | 0.100 |
Why?
|
| Pain | 1 | 1995 | 407 | 0.100 |
Why?
|
| Mucocele | 1 | 2012 | 2 | 0.100 |
Why?
|
| Esophageal Diseases | 1 | 2012 | 17 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2012 | 25 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2003 | 200 | 0.090 |
Why?
|
| Heparin | 1 | 1993 | 116 | 0.090 |
Why?
|
| Hepatic Artery | 1 | 2012 | 21 | 0.090 |
Why?
|
| Hemorrhage | 2 | 1993 | 274 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 131 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 1993 | 193 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2012 | 139 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 356 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2012 | 229 | 0.080 |
Why?
|
| Polyps | 1 | 2010 | 4 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 800 | 0.080 |
Why?
|
| Acute Disease | 2 | 2004 | 672 | 0.080 |
Why?
|
| Gallbladder Diseases | 1 | 2010 | 27 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1681 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2010 | 47 | 0.080 |
Why?
|
| Hospitalization | 1 | 2017 | 1368 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2010 | 64 | 0.080 |
Why?
|
| Equipment Failure | 2 | 2007 | 68 | 0.080 |
Why?
|
| Blood Volume | 2 | 2008 | 40 | 0.080 |
Why?
|
| Vascular Patency | 3 | 2006 | 134 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1118 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1130 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2010 | 160 | 0.070 |
Why?
|
| Angiography | 4 | 2015 | 151 | 0.070 |
Why?
|
| Bibliometrics | 1 | 2008 | 31 | 0.070 |
Why?
|
| Cineradiography | 1 | 2008 | 1 | 0.070 |
Why?
|
| Diatrizoate Meglumine | 1 | 2008 | 6 | 0.070 |
Why?
|
| Gastrointestinal Transit | 1 | 2008 | 6 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2008 | 31 | 0.070 |
Why?
|
| Young Adult | 2 | 2018 | 4776 | 0.070 |
Why?
|
| Injections | 2 | 2005 | 82 | 0.070 |
Why?
|
| Risk Factors | 3 | 2012 | 5339 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 70 | 0.070 |
Why?
|
| Atherectomy | 2 | 1997 | 8 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 766 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 119 | 0.060 |
Why?
|
| Alprostadil | 1 | 2005 | 6 | 0.060 |
Why?
|
| Phentolamine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2007 | 199 | 0.060 |
Why?
|
| Papaverine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Triiodobenzoic Acids | 1 | 2005 | 11 | 0.060 |
Why?
|
| Sildenafil Citrate | 1 | 2005 | 14 | 0.060 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2005 | 16 | 0.060 |
Why?
|
| Sulfones | 1 | 2005 | 41 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 175 | 0.060 |
Why?
|
| Purines | 1 | 2005 | 42 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 297 | 0.060 |
Why?
|
| Patient Selection | 1 | 2007 | 487 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 374 | 0.050 |
Why?
|
| Radiology | 1 | 2008 | 257 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2478 | 0.050 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 16 | 0.050 |
Why?
|
| Logistic Models | 1 | 2007 | 1270 | 0.050 |
Why?
|
| Vena Cava Filters | 1 | 2003 | 21 | 0.050 |
Why?
|
| Embolism | 1 | 2003 | 41 | 0.050 |
Why?
|
| Mesenteric Veins | 2 | 2000 | 11 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 21 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2003 | 193 | 0.050 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 21 | 0.050 |
Why?
|
| Mammary Arteries | 1 | 2001 | 11 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2002 | 30 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 240 | 0.040 |
Why?
|
| Recurrence | 2 | 2001 | 650 | 0.040 |
Why?
|
| Mass Screening | 1 | 2007 | 693 | 0.040 |
Why?
|
| Pancreaticojejunostomy | 1 | 2001 | 5 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2001 | 14 | 0.040 |
Why?
|
| Equipment Design | 1 | 2002 | 361 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2003 | 482 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 116 | 0.040 |
Why?
|
| Heart | 1 | 2002 | 288 | 0.040 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2000 | 15 | 0.040 |
Why?
|
| Intermittent Claudication | 2 | 1997 | 52 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 1997 | 278 | 0.040 |
Why?
|
| Leg | 2 | 1996 | 87 | 0.040 |
Why?
|
| Common Bile Duct Diseases | 1 | 1998 | 10 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2000 | 108 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 1998 | 38 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 1998 | 31 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1998 | 41 | 0.040 |
Why?
|
| Urography | 1 | 1998 | 13 | 0.040 |
Why?
|
| Ureter | 1 | 1998 | 37 | 0.030 |
Why?
|
| Costs and Cost Analysis | 2 | 1995 | 102 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 1997 | 52 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 482 | 0.030 |
Why?
|
| Adolescent | 2 | 1999 | 6304 | 0.030 |
Why?
|
| Iliac Artery | 1 | 1996 | 43 | 0.030 |
Why?
|
| Animals | 3 | 2003 | 20961 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1996 | 65 | 0.030 |
Why?
|
| Veins | 1 | 1996 | 64 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 1996 | 65 | 0.030 |
Why?
|
| Kidney | 1 | 1998 | 455 | 0.030 |
Why?
|
| Causality | 1 | 1995 | 59 | 0.030 |
Why?
|
| Thromboembolism | 1 | 1996 | 73 | 0.030 |
Why?
|
| Radiology, Interventional | 1 | 1995 | 31 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 868 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 87 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 32 | 0.030 |
Why?
|
| Time Factors | 2 | 2003 | 3724 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1995 | 214 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1993 | 33 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2012 | 22 | 0.020 |
Why?
|
| Hematoma | 1 | 1993 | 80 | 0.020 |
Why?
|
| Predictive Value of Tests | 4 | 1997 | 1102 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 174 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 1992 | 45 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 1992 | 77 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 1992 | 47 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 467 | 0.020 |
Why?
|
| Prevalence | 1 | 1995 | 1407 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 756 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 117 | 0.020 |
Why?
|
| Lung | 1 | 1996 | 964 | 0.020 |
Why?
|
| Gallbladder Neoplasms | 1 | 2010 | 16 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 2010 | 34 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 327 | 0.020 |
Why?
|
| Pressure | 2 | 2000 | 78 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 158 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 512 | 0.020 |
Why?
|
| Observer Variation | 2 | 1998 | 214 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2001 | 32 | 0.010 |
Why?
|
| Retreatment | 1 | 2000 | 44 | 0.010 |
Why?
|
| Transducers | 1 | 2000 | 26 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2000 | 54 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 23 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2000 | 167 | 0.010 |
Why?
|
| Necrosis | 1 | 1999 | 144 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 316 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 490 | 0.010 |
Why?
|
| Kidney Calices | 1 | 1998 | 1 | 0.010 |
Why?
|
| Ureteral Diseases | 1 | 1998 | 4 | 0.010 |
Why?
|
| Supine Position | 1 | 1998 | 33 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 1998 | 13 | 0.010 |
Why?
|
| Prone Position | 1 | 1998 | 28 | 0.010 |
Why?
|
| Urothelium | 1 | 1998 | 22 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 106 | 0.010 |
Why?
|
| Hematuria | 1 | 1998 | 23 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1998 | 45 | 0.010 |
Why?
|
| Abdomen | 1 | 1998 | 93 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1997 | 10 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1998 | 180 | 0.010 |
Why?
|
| Life Tables | 1 | 1996 | 23 | 0.010 |
Why?
|
| Ankle | 1 | 1996 | 28 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 128 | 0.010 |
Why?
|
| Physical Examination | 1 | 1996 | 111 | 0.010 |
Why?
|
| Aneurysm | 1 | 1996 | 58 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 747 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1996 | 517 | 0.010 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 1996 | 219 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1996 | 1272 | 0.010 |
Why?
|
| Mediastinal Diseases | 1 | 1992 | 15 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 1383 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 2217 | 0.000 |
Why?
|
| Neoplasms | 1 | 1995 | 1392 | 0.000 |
Why?
|